Immuno-modulating agents
Showing 1 - 25 of 6,679
Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma
Recruiting
- Multiple Myeloma
- Stem Cell Transplant
-
Firenze, Italy
- +1 more
Aug 19, 2021
Crohn's Disease, Ulcerative Colitis Trial in Montpellier (Immuno monitoring)
Completed
- Crohn's Disease
- Ulcerative Colitis
- Immuno monitoring
-
Montpellier, FranceUniversity hospital
Dec 13, 2022
Ulcerative Colitis Trial in Bonheiden, Leuven (Rosuvastatin 10mg)
Recruiting
- Ulcerative Colitis
- Rosuvastatin 10mg
-
Bonheiden, Antwerp, Belgium
- +1 more
May 6, 2021
Dengue, Dengue With Warning Signs, Severe Dengue Trial in Ho Chi Minh (Placebo, Anakinra)
Not yet recruiting
- Dengue
- +8 more
- Placebo
- Anakinra
-
Ho Chi Minh, VietnamHospital for Tropical Diseases
Nov 3, 2022
Cancer Trial in Chicago (Nivolumab, Cabiralizumab, Urelumab)
Active, not recruiting
- Cancer
- Nivolumab
- +3 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Mar 14, 2022
Cancer, Carcinoma, Squamous Cell Carcinoma Trial in San Francisco (Atezolizumab, Tocilizumab, Tiragolumab)
Recruiting
- Cancer
- +3 more
- Atezolizumab
- +2 more
-
San Francisco, CaliforniaUniversity of San Francisco, California
Feb 1, 2022
Chronic Kidney Disease Requiring Chronic Dialysis Trial in Derby (Immuno-nutrition supplement)
Completed
- Chronic Kidney Disease Requiring Chronic Dialysis
- Immuno-nutrition supplement
-
Derby, Derbyshire, United KingdomDepartment of Renal Medicine, Royal Derby Hospital
Jan 18, 2023
Biliary Tract Tumors Trial in Seoul (Durvalumab, Tremelimumab, Gemcitabine)
Active, not recruiting
- Biliary Tract Neoplasms
- Durvalumab
- +3 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 26, 2021
Cancer, Radiotherapy Side Effect Trial in Montreal (Radiotherapy)
Recruiting
- Cancer
- Radiotherapy Side Effect
- Radiotherapy
-
Montreal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Mar 14, 2022
Metastatic Melanoma Trial in Worldwide (LGX818, MEK162, Nivolumab)
Active, not recruiting
- Metastatic Melanoma
- LGX818
- +3 more
-
Salzburg, AT, Austria
- +29 more
Feb 23, 2022
Metastatic Castration-resistant Prostate Cancer Trial in Mexico City (SV-102)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
-
Mexico City, MexicoHospital Diomed
Sep 14, 2022
Kidney Transplant, Immunosuppression, Allograft Trial (KidneyCare, steroid, MMF)
Not yet recruiting
- Kidney Transplant
- +2 more
- KidneyCare
- +2 more
- (no location specified)
Jun 22, 2022
Hepatocellular Carcinoma Trial in Worldwide (Nivolumab, Sorafenib, Ipilimumab)
Active, not recruiting
- Hepatocellular Carcinoma
- Nivolumab
- +3 more
-
Los Angeles, California
- +58 more
Dec 1, 2021
Heart Transplant, Immunosuppression, Allograft Trial (HeartCare)
Not yet recruiting
- Heart Transplant
- +2 more
- HeartCare
- (no location specified)
Jul 12, 2022
Delirium, Postoperative Trial (Dexmedetomidine Injection [Precedex], Lidocaine IV, normal saline)
Not yet recruiting
- Delirium, Postoperative
- Dexmedetomidine Injection [Precedex]
- +2 more
- (no location specified)
Oct 15, 2023
Bladder Cancer, Bacillus Calmette-Guerin Trial in Campinas (Bacillus Calmette Guerin, PLACEBO)
Active, not recruiting
- Bladder Cancer
- Bacillus Calmette-Guerin
- Bacillus Calmette Guerin
- PLACEBO
-
Campinas, SP, BrazilHospital das Clínicas Unicamp
May 18, 2022
Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics Trial (Empagliflozin,
Not yet recruiting
- Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
- (no location specified)
Jan 22, 2023
Diabete Mellitus, Amputation, Amputation Wound Trial in Chambéry (Honey dressing Melectis G, HAS recommendation dressing)
Completed
- Diabete Mellitus
- +3 more
- Honey dressing Melectis G
- HAS recommendation dressing
-
Chambéry, FranceHélène Blaise
Jun 20, 2022
CFTR-modulating Triple Therapy Elexacaftor - Tezacaftor -
Recruiting
- Cystic Fibrosis
- Elexacaftor / Ivacaftor / Tezacaftor
-
Erlangen, Bavaria, GermanyUniversity Hospital Erlange, Department of Pediatrics
Oct 7, 2022